Addiction & Criminology

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.
Reach Us +44-1518-081136

Perspective - Addiction & Criminology (2023) Volume 6, Issue 3

Psychoactive drugs and their impact on brain function.

William Navot*

Department of Criminology, Saint Louis University, Spain

*Corresponding Author:
William Navot
Department of Psychiatry, The University of Michigan, Arizona, USA, The University of Michigan, USA

Received: 30-May -2023, Manuscript No. AARA-23-104028; Editor assigned: 01-June-2023, PreQC No. AARA-23-104028 (PQ); Reviewed:15-June-2023, QC No. AARA-23-104028; Revised:20-June-2023, Manuscript No. AARA-23-104028 (R); Published:27-June-2023, DOI:10.35841/aara-6.3.148

Citation: Navot W. Psychoactive drugs and their impact on brain function. Addict Criminol. 2023; 6(3):148

Visit for more related articles at Addiction & Criminology


Psychoactive drugs have long been recognized for their ability to alter brain function and induce various behavioral and psychological effects. Advancements in neuroscience research have provided valuable insights into the mechanisms underlying these effects, shedding light on the impact of psychoactive drugs on brain function. This article aims to explore the current understanding of how these drugs influence the brain, drawing on findings from neuroscience research [1].

Neurotransmitter systems play a critical role in mediating the effects of psychoactive drugs. Different classes of drugs, such as opioids, stimulants, and sedatives, interact with specific neurotransmitter receptors, modulating their activity and resulting in distinct physiological and behavioral responses. For example, opioids bind to opioid receptors in the brain, leading to pain relief and euphoria, while stimulants like amphetamines increase the release and inhibit the reuptake of dopamine, producing heightened arousal and a sense of reward. Similarly, sedatives enhance the inhibitory effects of the neurotransmitter GABA, leading to relaxation and sedation [2].

Neuroimaging techniques, such as functional magnetic resonance imaging (fMRI) and positron emission tomography (PET), have played a crucial role in elucidating the neural mechanisms underlying psychoactive drug effects. These studies have revealed specific brain regions and networks that are altered by drug exposure. For instance, drugs of abuse, such as cocaine and methamphetamine, have been shown to activate the brain's reward circuitry, including the nucleus accumbens and prefrontal cortex, contributing to the reinforcing effects of these substances. Other drugs, like cannabis, have been found to affect regions involved in memory, attention, and emotion processing. Moreover, long-term drug use induces neuroadaptations in the brain that contribute to tolerance, dependence, and addiction. Neuroplasticity, the brain's ability to change and adapt, plays a significant role in these adaptations. Chronic drug exposure can lead to alterations in synaptic strength and connectivity, as well as changes in gene expression. These neurobiological changes contribute to the development of addictive behaviors and the persistence of drug cravings, even after long periods of abstinence [3].

Understanding the impact of psychoactive drugs on brain function has implications for both addiction treatment and mental health interventions. Targeting the neurochemical systems affected by these drugs can aid in the development of pharmacotherapies to mitigate withdrawal symptoms and cravings, improving treatment outcomes. Additionally, research has shown promising therapeutic effects of certain psychoactive drugs in mental health conditions. For example, psychedelic substances like psilocybin and MDMA have demonstrated potential in the treatment of depression, post-traumatic stress disorder (PTSD), and addiction. These substances are thought to exert their therapeutic effects by modulating neural circuits involved in emotion processing and self-reflection [4].

However, it is important to note that the use of psychoactive drugs is not without risks. Prolonged or excessive drug use can lead to detrimental effects on brain structure and function. Chronic drug abuse is associated with cognitive impairments, including deficits in attention, memory, and executive function. Furthermore, certain drugs can increase the risk of developing mental health disorders, such as anxiety and psychosis, particularly in individuals with pre-existing vulnerabilities [5].


In conclusion, neuroscience research has significantly advanced our understanding of how psychoactive drugs impact brain function. By uncovering the neurochemical, neural circuit, and molecular mechanisms involved, we gain valuable insights into the complex effects of these substances on behavior and cognition. This knowledge is crucial for developing targeted interventions for substance use disorders and exploring the therapeutic potential of psychoactive drugs in mental health treatment. However, further research is needed to fully comprehend the intricacies of these effects and their long-term consequences on brain function.


  1. Nagai F, Nonaka R, Kamimura KS. The effects of non-medically used psychoactive drugs on monoamine neurotransmission in rat brain. Eur J Pharmacol. 2007;559(2-3):132-7.
  2. Indexed at, Google Scholar, Cross Ref

  3. Whittington MA, Faulkner HJ, Doheny HC, et al. Neuronal fast oscillations as a target site for psychoactive drugs. Pharmacol Ther. 2000;86(2):171-90.
  4. Indexed at, Google Scholar, Cross Ref

  5. Nutt DJ, King LA, Nichols DE. Effects of Schedule I drug laws on neuroscience research and treatment innovation. Nat Rev Neurosci. 2013;14(8):577-85.
  6. Indexed at, Google Scholar, Cross Ref

  7. Chastain G. Alcohol, neurotransmitter systems, and behavior. J Gen Psychol. 2006;133(4):329-35.
  8. Indexed at, Google Scholar, Cross Ref

  9. Mattson MP, Moehl K, Ghena N, et al. Intermittent metabolic switching, neuroplasticity and brain health. Nat Rev Neurosci. 2018;19(2):81-94.
  10. Indexed at, Google Scholar, Cross Ref

Get the App